Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.70 |
| ▸ | CA1 | P00915 | 1/20 | 0.70 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.66 |
| ▸ | BIRC2 | Q13490 | 5/20 | 0.51 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19522393 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL16950292 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL18597131 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL18429981 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL21356697 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL17199802 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL21356682 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL21356686 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL21356695 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 | |
| SCHEMBL5590767 | 1.00 | CA2 (0.70) | CA2CA1ZDHHC7BIRC2ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2271661-B3 | Derivatives of muramylpeptide | IMUTHES LTD (GB) | 2014-08-20 | — | — | EP | disclosed |
| US-8653049-B2 | Normuramyl glycopeptide compounds | IMUTHES LIMITED (GB) | 2014-02-18 | — | — | US | disclosed |
| EP-2578598-A1 | Componds derived from normuramyldipeptide | IMUTHES LIMITED (GB) | 2013-04-10 | — | — | EP | disclosed |
| EP-2271661-B1 | Derivatives of muramylpeptide | IMUTHES LTD (GB) | 2013-02-27 | — | — | EP | disclosed |
| EP-2271661-A2 | COMPOUNDS DERIVED FROM MURAMYLDIPEPTIDE | IMUTHES LIMITED (GB) | 2011-01-12 | — | — | EP | disclosed |
| US-20110002983-A1 | COMPOUND | IMUTHES LIMITED (GB) | 2011-01-06 | — | — | US | disclosed |
| WO-2009115782-A2 | COMPOUND | IMUTHES LIMITED (GB) | 2009-09-24 | — | — | WO | disclosed |
| US-5589465-A | Glycolipid derivatives acting as ligands for selectins | Hasegawa, Akira (JP) | 1996-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110002983-A1 | COMPOUND | C5AR1, C5AR2, ARG1 | CA2 1291/4885CA1 605/4885ZDHHC7 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.